The iconic rise of Viagra has consistently remained a benchmark of pharmaceutical success, yet its legacy within the broader industry now raises questions about long-term returns . Alternative versions are diminishing exclusivity , leading to anxieties that supporting companies heavily reliant to Viagra's once-dominant influence could be a speculat